237 related articles for article (PubMed ID: 22639106)
21. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
22. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Rodriguez J; Romaguera JE; Manning J; Ordonez N; Ha C; Ravandi F; Cabanillas F
Leuk Lymphoma; 2000 Sep; 39(1-2):139-44. PubMed ID: 10975392
[TBL] [Abstract][Full Text] [Related]
23. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Yamaguchi M; Suzuki R; Miyazaki K; Amaki J; Takizawa J; Sekiguchi N; Kinoshita S; Tomita N; Wada H; Kobayashi Y; Niitsu N; Ando T; Maeda T; Saito B; Matsuoka H; Sakai R; Kubota N; Masaki Y; Kameoka Y; Asano N; Oguchi M; Katayama N
Ann Hematol; 2019 Jul; 98(7):1647-1655. PubMed ID: 31001658
[TBL] [Abstract][Full Text] [Related]
24. Natural killer-cell neoplasms.
Greer JP; Mosse CA
Curr Hematol Malig Rep; 2009 Oct; 4(4):245-52. PubMed ID: 20425414
[TBL] [Abstract][Full Text] [Related]
25. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
26. In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A.
Uno M; Tsuchiyama J; Moriwaki A; Noguchi T; Mizoguchi K; Ogino T; Yoshino T; Okada S; Harada M
Br J Haematol; 2001 Jun; 113(4):1009-14. PubMed ID: 11442496
[TBL] [Abstract][Full Text] [Related]
27. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
28. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
Peh SC; Quen QW
Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Tajima S; Takanashi Y; Koda K; Fukayama M
Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
31. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
Suzuki R; Takeuchi K; Ohshima K; Nakamura S
Hematol Oncol; 2008 Jun; 26(2):66-72. PubMed ID: 18283711
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
Tse E; Au-Yeung R; Kwong YL
Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
[No Abstract] [Full Text] [Related]
34. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
Kuo TT; Shih LY; Tsang NM
Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
[TBL] [Abstract][Full Text] [Related]
35. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Kwong YL
J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
37. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
38. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma.
Takahashi N; Miura I; Chubachi A; Miura AB; Nakamura S
Int J Hematol; 2001 Oct; 74(3):303-8. PubMed ID: 11721967
[TBL] [Abstract][Full Text] [Related]
39. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
Zhang S; Li T; Zhang B; Nong L; Aozasa K
Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
[TBL] [Abstract][Full Text] [Related]
40. Disseminated nasal-type natural killer/T-cell lymphoma in a child: a case report.
Pellier I; N'Golet L; Rachieru P; Rousselet MC; Geneviève F; Moles MP; Hermine O; Rialland X
J Pediatr Hematol Oncol; 2009 May; 31(5):362-6. PubMed ID: 19415021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]